Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Rewinding RX vs WeightRx

Rewinding RX
Graded #340

Lower grade

vs+10.900000000000006
WeightRx
Graded #106

Higher grade

The verdict

WeightRx takes it — 70.4/100 to 59.5/100.

WeightRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering one of the lowest monthly prices for compounded semaglutide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWeightRx +39
45
84
Dose & formulationWeightRx +24
40
64
Clinical oversightRewinding RX +3
85
82
Labs & monitoringEven
53
53
FulfillmentRewinding RX +22
87
65
Contract termsRewinding RX +6
61
55
Rewinding RX · left barWeightRx · right bar

The numbers

MetricRewinding RXWeightRx
WeighScore59.5/10070.4/100
GradeCC
Scorecard rank#340#106
SemaglutideNot disclosed$83/mo (starting dose, compounded)
TirzepatideNot disclosed$83/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Rewinding RX

Graded #340 · C

Strengths

  • LegitScript Certified
  • Publishes the FDA compounded-medication disclaimer — uncommon transparency
  • MD-only physician network ('never a physician assistant or nurse')
  • All-50-state coverage with physician state-licensing matching
  • Corporate entity disclosed (Rewinding RX Ltd.)

Where it loses points

  • Pricing not shown — fully gated behind sign-up
  • Pharmacy partner not named (only generic 503A/503B references)
  • Medical director / clinical leadership not disclosed
  • Governing law, arbitration venue, and corporate address not disclosed
  • Tirzepatide not listed on the homepage (semaglutide only confirmed)
WeightRx

Graded #106 · C

Strengths

  • Aggressively low monthly pricing
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard